
A new short device for percutaneous endoscopic cholangioscopy has undergone evaluation for feasibility and safety. In a study, 51 patients were assessed, primarily with altered anatomy and biliary stones. The clinical success rate reached 96.6%, often achieved in just one session, and 33.3% underwent cholangioscopy-guided biopsies. While technical success stood at 100%, cholangioscopy-related adverse events were limited to 7.8%. This study concludes that percutaneous endoscopic cholangioscopy with the new short device is a promising option for both duct clearance and diagnosis, offering safety and practicality.
Like
Save
Share